for appointments
(570) 288-3601

Riverview Urologic Associates

Riverview Urologic Associates is the oldest urological practice in Northeastern Pennsylvania. Our urology office is located in Kingston, PA which is just across the Susquehanna River from Wilkes-Barre and just minutes from Scranton, PA. We are proud to have served our community since 1911. Our physicians are certified by the American Board of Urology and our office is staffed by a knowledgeable, friendly, and compassionate group of mid-level providers, nurses, technicians, and clerical staff. Our team approach and our state-of-the-art office help to assure that our patients receive the highest quality, comprehensive care available anywhere.

Get Directions

Urology Treatment in Kingston, PA

The board certified urologists at Riverview Urologic Associates, in Kingston, PA specialize in the diagnosis and treatment of bladder, kidney, testicular and prostate cancer using minimally invasive surgical procedures. Our physicians also specialize in the treatment of conditions such as urinary incontinence, erectile dysfunction and urinary tract infections.

Health Library

BPH Treatment

Learn more about the causes and effects of an enlarged prostate and how to treat it. [ click here ]

Video Tutorials

Video Tutorials

View our patient education topics on prostatectomy, cystectomy and more.
[ click here ]

What's New in Urology?

da Vinci® Surgery
Learn more about da Vinci® Surgery.

Learn more about BPH
find out more about laser technology for BPH.

What's New in BPH Treatment

Prostate Cancer Screening Update:

 

Most recent guidelines for PSA prostate cancer screening from the AUA  (American Urologic Association), our governing body:

1)   The highest quality evidence for benefit (defined as lower prostate cancer mortality) of screening was found in men ages 55 to 69, and this evidence demonstrated that one man per 1,000 screened at two- to four-year intervals will avert a prostate cancer death over a decade. However, over a lifetime, this benefit could be much greater.

2)   The other key change is in men over age 70 or those with less than a 10-year life expectancy in whom routine screening is not recommended. However, the guidelines acknowledge that some men over age 70 in excellent health may benefit from screening. In this setting, the guidelines suggest that a discussion of the unique risks and benefits of screening in older men occur.

3)   The AUA remains in disagreement with the U.S. Preventive Services Task Force in recommendation against prostate cancer screening in all men, regardless of age or risk, without even considering a discussion of the risks and benefits of screening. The AUA continues to support a man's right to be tested for prostate cancer and to have his insurance pay for it, if medically necessary.